Is RNAZ or RNTX more undervalued in 2026?

CirclFi compares TransCode Therapeutics, Inc. (RNAZ) and Rein Therapeutics, Inc. (RNTX) using 13 institutional-grade valuation models. RNAZ has a Quality of Company score of 3.9/10 while RNTX scores 3.6/10.

Which is a better buy — RNAZ or RNTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RNAZ and RNTX valuations compare?

RNAZ at $5.14 and RNTX at $1.11 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RNAZ vs RNTX Valuation Comparison 2026 — Intrinsic Value Analysis

RNAZ

Pharmaceutical Preparations

TransCode Therapeutics, Inc.

Quality

3.9

out of 10

Value Trap

LOW

Price

$5.14

Last close

Models

6/13

Active

RNTX

Pharmaceutical Preparations

Rein Therapeutics, Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$1.11

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	RNAZ Fair Value	RNAZ Upside	RNTX Fair Value	RNTX Upside
Bayesian DCF	Intrinsic	$9.29	+80.8%	$0.03	-97.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$0.32	-69.0%
PWERM	Option-Based	$18.92	+268.1%	$0.57	-48.7%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RNAZ vs RNTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RNAZ vs RNTX — Which Stock Is More Undervalued?

RNAZ scores higher with a 3.9/10 quality rating vs RNTX's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing TransCode Therapeutics, Inc. (RNAZ) and Rein Therapeutics, Inc. (RNTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RNAZ currently trades at $5.14 with a QOC of 3.9/10, while RNTX trades at $1.11 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).